BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37040077)

  • 21. Variations in IgG antibody subclass responses to oral bacteria: Effects of periodontal disease and modifying factors.
    Ebersole JL; Hamzeh R; Nguyen L; Al-Sabbagh M; Dawson D
    J Periodontal Res; 2021 Oct; 56(5):863-876. PubMed ID: 33826149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum antibody levels against Porphyromonas gingivalis extract and its chromatographic fraction in chronic and aggressive periodontitis.
    Trindade SC; Gomes-Filho IS; Meyer RJ; Vale VC; Pugliese L; Freire SM
    J Int Acad Periodontol; 2008 Apr; 10(2):50-8. PubMed ID: 18564729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IgG subclass specific antibody response to periodontopathic organisms in HIV-positive patients.
    Yeung SC; Taylor BA; Sherson W; Lazarus R; Zhao ZZ; Bird PS; Hamlet SM; Bannon M; Daly C; Seymour GJ
    J Periodontol; 2002 Dec; 73(12):1444-50. PubMed ID: 12546094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Salivary IgA and IgG Antibody Responses against Periodontitis-Associated Bacteria in Crohn's Disease.
    Gürsoy M; Rautava J; Pussinen P; Kristoffersen AK; Enersen M; Loimaranta V; Gürsoy UK
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum IgG antibody levels to periodontal microbiota are associated with incident Alzheimer disease.
    Noble JM; Scarmeas N; Celenti RS; Elkind MS; Wright CB; Schupf N; Papapanou PN
    PLoS One; 2014; 9(12):e114959. PubMed ID: 25522313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study.
    Michaud DS; Izard J; Wilhelm-Benartzi CS; You DH; Grote VA; Tjønneland A; Dahm CC; Overvad K; Jenab M; Fedirko V; Boutron-Ruault MC; Clavel-Chapelon F; Racine A; Kaaks R; Boeing H; Foerster J; Trichopoulou A; Lagiou P; Trichopoulos D; Sacerdote C; Sieri S; Palli D; Tumino R; Panico S; Siersema PD; Peeters PH; Lund E; Barricarte A; Huerta JM; Molina-Montes E; Dorronsoro M; Quirós JR; Duell EJ; Ye W; Sund M; Lindkvist B; Johansen D; Khaw KT; Wareham N; Travis RC; Vineis P; Bueno-de-Mesquita HB; Riboli E
    Gut; 2013 Dec; 62(12):1764-70. PubMed ID: 22990306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell envelope and cell wall immunization of Macaca fascicularis: effect on the progression of ligature-induced periodontitis.
    Holt SC; Brunsvold M; Jones A; Wood R; Ebersole JL
    Oral Microbiol Immunol; 1995 Dec; 10(6):321-33. PubMed ID: 8602339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preoperative serum immunoglobulin G and A antibodies to Porphyromonas gingivalis are potential serum biomarkers for the diagnosis and prognosis of esophageal squamous cell carcinoma.
    Gao SG; Yang JQ; Ma ZK; Yuan X; Zhao C; Wang GC; Wei H; Feng XS; Qi YJ
    BMC Cancer; 2018 Jan; 18(1):17. PubMed ID: 29298684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Porphyromonas gingivalis, Bacteroides forsythus and other putative periodontal pathogens in subjects with and without periodontal destruction.
    van Winkelhoff AJ; Loos BG; van der Reijden WA; van der Velden U
    J Clin Periodontol; 2002 Nov; 29(11):1023-8. PubMed ID: 12472995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Periodontal treatment decreases levels of antibodies to Porphyromonas gingivalis and citrulline in patients with rheumatoid arthritis and periodontitis.
    Okada M; Kobayashi T; Ito S; Yokoyama T; Abe A; Murasawa A; Yoshie H
    J Periodontol; 2013 Dec; 84(12):e74-84. PubMed ID: 23701010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibodies to oral pathobionts and colon cancer risk in the CLUE I cohort study.
    Debertin J; Teles F; Martin LM; Lu J; Koestler DC; Kelsey KT; Beck JD; Platz EA; Michaud DS
    Int J Cancer; 2023 Jul; 153(2):302-311. PubMed ID: 36971101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Porphyromonas gingivalis-specific IgG subclass antibody levels as immunological risk indicators of periodontal bone loss.
    Sakai Y; Shimauchi H; Ito HO; Kitamura M; Okada H
    J Clin Periodontol; 2001 Sep; 28(9):853-9. PubMed ID: 11493355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inverse Association of Plasma IgG Antibody to Aggregatibacter actinomycetemcomitans and High C-Reactive Protein Levels in Patients with Metabolic Syndrome and Periodontitis.
    Thanakun S; Pornprasertsuk-Damrongsri S; Gokyu M; Kobayashi H; Izumi Y
    PLoS One; 2016; 11(2):e0148638. PubMed ID: 26871443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Salivary pathogen and serum antibody to assess the progression of chronic periodontitis: a 24-mo prospective multicenter cohort study.
    Morozumi T; Nakagawa T; Nomura Y; Sugaya T; Kawanami M; Suzuki F; Takahashi K; Abe Y; Sato S; Makino-Oi A; Saito A; Takano S; Minabe M; Nakayama Y; Ogata Y; Kobayashi H; Izumi Y; Sugano N; Ito K; Sekino S; Numabe Y; Fukaya C; Yoshinari N; Fukuda M; Noguchi T; Kono T; Umeda M; Fujise O; Nishimura F; Yoshimura A; Hara Y; Nakamura T; Noguchi K; Kakuta E; Hanada N; Takashiba S; Yoshie H
    J Periodontal Res; 2016 Dec; 51(6):768-778. PubMed ID: 26791469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of anti-Porphyromonas gingivalis peptidylarginine deiminase immunoglobulin G and peptidylarginine deiminase-4 in patients with rheumatoid arthritis and periodontitis.
    Shimada A; Kobayashi T; Ito S; Okada M; Murasawa A; Nakazono K; Yoshie H
    J Periodontal Res; 2016 Feb; 51(1):103-11. PubMed ID: 26094771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ovine periodontitis as a potential model for periodontal studies. Cross-sectional analysis of clinical, microbiological, and serum immunological parameters.
    Duncan WJ; Persson GR; Sims TJ; Braham P; Pack AR; Page RC
    J Clin Periodontol; 2003 Jan; 30(1):63-72. PubMed ID: 12702113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between serum antibody levels and subgingival colonization of Porphyromonas gingivalis in patients with various types of periodontitis.
    Kojima T; Yano K; Ishikawa I
    J Periodontol; 1997 Jul; 68(7):618-25. PubMed ID: 9249632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic immune responses in pregnancy and periodontitis: relationship to pregnancy outcomes in the Obstetrics and Periodontal Therapy (OPT) study.
    Ebersole JL; Novak MJ; Michalowicz BS; Hodges JS; Steffen MJ; Ferguson JE; Diangelis A; Buchanan W; Mitchell DA; Papapanou PN
    J Periodontol; 2009 Jun; 80(6):953-60. PubMed ID: 19485826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The association between Porphyromonas gingivalis-specific maternal serum IgG and low birth weight.
    Dasanayake AP; Boyd D; Madianos PN; Offenbacher S; Hills E
    J Periodontol; 2001 Nov; 72(11):1491-7. PubMed ID: 11759860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA-based adaptive immunity protect host from infection-associated periodontal bone resorption via recognition of Porphyromonas gingivalis virulence component.
    Han X; LaRosa KB; Kawai T; Taubman MA
    Vaccine; 2014 Jan; 32(2):297-303. PubMed ID: 24051159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.